Central Florida Pulmonary Group is a clinical research site located in Orlando, Florida, United States 32803.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Central Florida Pulmonary Group has participated in 28 clinical trials with 5 currently active.
Therapeutic areas: Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Bronchiectasis.
Sponsors: National Heart, Lung, and Blood Institute (NHLBI), Vertex Pharmaceuticals Incorporated, Gilead Sciences.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Central Florida Pulmonary Group has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Florida Pulmonary Group has 28 clinical trials on record, with 5 currently active. Their work covers Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Bronchiectasis.
Yes — Central Florida Pulmonary Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.